TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Renapharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,722
|
2,710
|
2,259 |
Financial expenses |
7
|
3
|
11 |
Earnings before taxes |
595
|
663
|
779 |
EBITDA |
646
|
710
|
901 |
Total assets |
3,989
|
3,337
|
2,541 |
Current assets |
1,954
|
1,747
|
951 |
Current liabilities |
871
|
693
|
205 |
Equity capital |
2,388
|
1,788
|
1,224 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.9%
|
53.6%
|
48.2% |
Turnover per employee |
680
|
678
|
753 |
Profit as a percentage of turnover |
21.9%
|
24.5%
|
34.5% |
Return on assets (ROA) |
15.1%
|
20.0%
|
31.1% |
Current ratio |
224.3%
|
252.1%
|
463.9% |
Return on equity (ROE) |
24.9%
|
37.1%
|
63.6% |
Change turnover |
4
|
634
|
575 |
Change turnover % |
0%
|
31%
|
34% |
Chg. No. of employees |
0
|
1
|
-1 |
Chg. No. of employees % |
0%
|
33%
|
-25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.